190 related articles for article (PubMed ID: 8003767)
1. Behavior and immune status of MRL mice in the postweaning period.
Sakić B; Szechtman H; Talangbayan H; Denburg S; Carbotte R; Denburg JA
Brain Behav Immun; 1994 Mar; 8(1):1-13. PubMed ID: 8003767
[TBL] [Abstract][Full Text] [Related]
2. A behavioral profile of autoimmune lupus-prone MRL mice.
Sakić B; Szechtman H; Keffer M; Talangbayan H; Stead R; Denburg JA
Brain Behav Immun; 1992 Sep; 6(3):265-85. PubMed ID: 1392101
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal antibodies and brain damage in autoimmune MRL mice.
Stanojcic M; Loheswaran G; Xu L; Hoffman SA; Sakic B
Brain Behav Immun; 2010 Feb; 24(2):289-97. PubMed ID: 19853033
[TBL] [Abstract][Full Text] [Related]
4. Age and lpr dependent induction of increased sensitivity to the toxic effects of lipopolysaccharide and indomethacin in MRL mice: evidence for RES activation during disease progression.
Hart DA
J Clin Lab Immunol; 1988 Jul; 26(3):129-34. PubMed ID: 3230580
[TBL] [Abstract][Full Text] [Related]
5. Proclivity to self-injurious behavior in MRL-lpr mice: implications for autoimmunity-induced damage in the dopaminergic system.
Chun S; McEvilly R; Foster JA; Sakic B
Mol Psychiatry; 2008 Nov; 13(11):1043-53. PubMed ID: 17768421
[TBL] [Abstract][Full Text] [Related]
6. Analysis of granulomatous arteritis in MRL/Mp autoimmune disease mice bearing lymphoproliferative genes. The use of mouse genetics to dissociate the development of arteritis and glomerulonephritis.
Nose M; Nishimura M; Kyogoku M
Am J Pathol; 1989 Aug; 135(2):271-80. PubMed ID: 2782373
[TBL] [Abstract][Full Text] [Related]
7. Lpr and MRL background gene involvement in the control of adjuvant enhanced arthritis in MRL-lpr mice.
Ratkay LG; Tait B; Tonzetich J; Waterfield JD
J Autoimmun; 1994 Oct; 7(5):561-73. PubMed ID: 7530961
[TBL] [Abstract][Full Text] [Related]
8. Behavior, cortical ectopias, and autoimmunity in BXSB-Yaa and BXSB-Yaa+ mice.
Schrott LM; Waters NS; Boehm GW; Sherman GF; Morrison L; Rosen GD; Behan PO; Galaburda AM; Denenberg VH
Brain Behav Immun; 1993 Sep; 7(3):205-23. PubMed ID: 8147964
[TBL] [Abstract][Full Text] [Related]
9. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
[TBL] [Abstract][Full Text] [Related]
10. Elevated plus maze behavior, auditory startle response, and shock sensitivity in predisease and in early stage autoimmune disease MRL/lpr mice.
Nielsen DM; Crnic LS
Brain Behav Immun; 2002 Feb; 16(1):46-61. PubMed ID: 11846440
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic significance of serum components in the development of autoimmune polyarthritis in MRL/Mp mice bearing the lymphoproliferation gene.
Itoh J; Nose M; Kyogoku M
Am J Pathol; 1991 Sep; 139(3):511-21. PubMed ID: 1887861
[TBL] [Abstract][Full Text] [Related]
12. An epistatic effect of the female specific loci on the development of autoimmune vasculitis and antinuclear autoantibody in murine lupus.
Zhang MC; Misu N; Furukawa H; Watanabe Y; Terada M; Komori H; Miyazaki T; Nose M; Ono M
Ann Rheum Dis; 2006 Apr; 65(4):495-500. PubMed ID: 16150787
[TBL] [Abstract][Full Text] [Related]
13. The influence of silicone implantation on murine lupus in MRL lpr/lpr mice.
Schaefer CJ; Wooley PH
J Rheumatol; 1999 Oct; 26(10):2215-21. PubMed ID: 10529143
[TBL] [Abstract][Full Text] [Related]
14. Defective neutrophil function in the autoimmune mouse strain MRL/lpr. Potential role of transforming growth factor-beta.
Gresham HD; Ray CJ; O'Sullivan FX
J Immunol; 1991 Jun; 146(11):3911-21. PubMed ID: 1674521
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune MRL/lpr mice sera contain IgG with interleukin 3-like activity.
Ohta Y; Tamura S; Tezuka E; Sugawara M; Imai S; Tanaka H
J Immunol; 1988 Jan; 140(2):520-5. PubMed ID: 3257242
[TBL] [Abstract][Full Text] [Related]
16. A genetic locus controlling aging-sensitive regression of B lymphopoiesis in an autoimmune-prone MRL/lpr strain of mice.
Nakatani K; Qu WM; Zhang MC; Fujii H; Furukawa H; Miyazaki T; Iwano M; Saito Y; Nose M; Ono M
Scand J Immunol; 2007 Dec; 66(6):654-61. PubMed ID: 17983422
[TBL] [Abstract][Full Text] [Related]
17. Cognitive and neurologic deficits in the MRL/lpr mouse: a clinicopathologic study.
Hess DC; Taormina M; Thompson J; Sethi KD; Diamond B; Rao R; Chamberlain CR; Feldman DS
J Rheumatol; 1993 Apr; 20(4):610-7. PubMed ID: 8496852
[TBL] [Abstract][Full Text] [Related]
18. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
Gu L; Weinreb A; Wang XP; Zack DJ; Qiao JH; Weisbart R; Lusis AJ
J Immunol; 1998 Dec; 161(12):6999-7006. PubMed ID: 9862736
[TBL] [Abstract][Full Text] [Related]
19. MRL mice produce anti-Su autoantibody, a specificity associated with systemic lupus erythematosus.
Treadwell EL; Cohen P; Williams D; O'Brien K; Volkman A; Eisenberg R
J Immunol; 1993 Jan; 150(2):695-9. PubMed ID: 8419494
[TBL] [Abstract][Full Text] [Related]
20. Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect.
Ettinger R; Wang JK; Bossu P; Papas K; Sidman CL; Abbas AK; Marshak-Rothstein A
J Immunol; 1994 Feb; 152(4):1557-68. PubMed ID: 8120369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
